The global demand for Atopic Dermatitis Market is presumed to reach the market size of nearly USD 21.33 MN by 2028 from USD 7.41 MN in 2021 with a CAGR of 16.31% under the study period 2022 - 2028.
Atopic dermatitis leads to dry, itchy, and inflammatory skin. It is also called eczema. Although this can happen to anyone, it is more frequent in young children. Atopic dermatitis is persistent (chronic) and occasionally flares up. It is not generally contagious, but it can be not very pleasant. In addition, atopic dermatitis patients are at high risk of acquiring asthma, hay fever, and food allergies. Genetic abnormality, environmental exposure, a dysfunctional immune system, and a problem with skin permeability are the causes of atopic dermatitis.
Market Dynamics
The atopic dermatitis treatment market will flourish significantly during the projected period due to the rapid development of novel pipeline medications to heal the disease. Additionally, the growth of the atopic dermatitis sector and the rise in the demand for novel biologics and product approvals are expected to support the market's expansion. Additionally, the increased government initiatives to provide better and more cost-effective treatment and increased awareness of the disease's treatment alternatives will further generate the global market share for atopic dermatitis. Additionally, the rapid development of technology, the increase in funding, and the increasing government support for R&D activities will open several lucrative opportunities that will positively influence the growth of the atopic dermatitis market during the forecast period.
The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of atopic dermatitis. The growth and trends of atopic dermatitis industry provide a holistic approach to this study.
Market Segmentation
This section of the atopic dermatitis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Drug Class
- Pde-4 Inhibitor
- Corticosteroids
- Others
- Biologics
- Calcineurin Inhibitors
By Mode Of Administration
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Analysis
This section covers the regional outlook, which accentuates current and future demand for the Atopic Dermatitis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
Global Atopic Dermatitis Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the atopic dermatitis market include AbbVie Inc., Arcutis Biotherapeutics Inc., Asana Biosciences Inc., Astellas Pharma Inc., Bayer AG Inc., Bristol-Myers Squibb Inc., Dermavant Sciences Inc., Eli Lilly and Company Inc., Galderma Inc., Incyte Corporation Inc., Leo Pharma Inc., Novartis AG, Otsuka Pharmaceuticals Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA Inc., and Viatris Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
